Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...

Subtle symptoms can appear long before serious pancreatic conditions are diagnosed, and recognizing them early could make a ...

New experimental medications seem to extend survival with the hard-to-treat cancer.

They’re easy to mistake for other conditions.

Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

Learn why medical experts warn that "brushing off" common stomach issues could be a dangerous mistake and how your body ...

The overall risk of malignancy in pancreatic cysts may be as low as 0.5 to 1.5%, and the annual risk of progression is 0.5%. 7,15 Conversely, studies estimate that 15% of all pancreatic ...